KR100922605B1 - 바이러스 감염의 예방 및 치료용 약제를 제조하기 위한하이드록시벤조산 에스테르 및 유사체의 용도 - Google Patents
바이러스 감염의 예방 및 치료용 약제를 제조하기 위한하이드록시벤조산 에스테르 및 유사체의 용도 Download PDFInfo
- Publication number
- KR100922605B1 KR100922605B1 KR1020087005140A KR20087005140A KR100922605B1 KR 100922605 B1 KR100922605 B1 KR 100922605B1 KR 1020087005140 A KR1020087005140 A KR 1020087005140A KR 20087005140 A KR20087005140 A KR 20087005140A KR 100922605 B1 KR100922605 B1 KR 100922605B1
- Authority
- KR
- South Korea
- Prior art keywords
- treatment
- hpv
- prevention
- hydroxybenzoic acid
- virus infection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
Claims (13)
- 삭제
- 제 1 항에 있어서,상기 HPV 바이러스 감염이 첨규형 콘딜로마, 질염, 자궁경부염, 자궁경부 미란 또는 자궁경부암인 것을 특징으로 하는,인간 또는 동물의 HPV 바이러스 감염의 예방 및 치료용 약제.
- 삭제
- 제 1 항 또는 제 3 항에 있어서,상기 R이 C1-8 알킬기인 것을 특징으로 하는,인간 또는 동물의 HPV 바이러스 감염의 예방 및 치료용 약제.
- 제 1 항 또는 제 3 항에 있어서,상기 R이 C1-3 알킬기인 것을 특징으로 하는,인간 또는 동물의 HPV 바이러스 감염의 예방 및 치료용 약제.
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 제 1 항 또는 제 3 항에 있어서,상기 약제는 주사 또는 경구 제형용 보조제와 함께 분말, 용액, 정제, 캡슐, 과립 또는 액체로 만들어지거나, 또는 피부 점막 제형용 보조제와 함께 연고, 젤, 로션, 정제, 좌제, 다이어프램 또는 스프레이로 만들어짐을 특징으로 하는,인간 또는 동물 HPV의 바이러스 감염의 예방 및 치료용 약제.
- 제 1 항 또는 제 3 항에 있어서,상기 약제는 퍼스널 케어 제품으로서 사용되고,이러한 퍼스널 케어 제품이 손비누, 손 소독제, 바디 클렌저, 바디 클렌징 젤, 바디 세척 비누, 퍼스널 케어 와이프, 고급화장지, 비강 스프레이 또는 이의 조합물인 것을 특징으로 하는,인간 또는 동물 HPV의 바이러스 감염의 예방 및 치료용 약제.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200510012287.0 | 2005-08-02 | ||
CNB2005100122870A CN100427082C (zh) | 2005-08-02 | 2005-08-02 | 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080036128A KR20080036128A (ko) | 2008-04-24 |
KR100922605B1 true KR100922605B1 (ko) | 2009-10-21 |
Family
ID=37698614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020087005140A KR100922605B1 (ko) | 2005-08-02 | 2006-07-21 | 바이러스 감염의 예방 및 치료용 약제를 제조하기 위한하이드록시벤조산 에스테르 및 유사체의 용도 |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1930002B1 (ko) |
JP (1) | JP5473328B2 (ko) |
KR (1) | KR100922605B1 (ko) |
CN (1) | CN100427082C (ko) |
AP (1) | AP2658A (ko) |
AU (1) | AU2006275232B2 (ko) |
BR (1) | BRPI0616536B8 (ko) |
CA (1) | CA2617659C (ko) |
CY (1) | CY1117480T1 (ko) |
DK (1) | DK1930002T3 (ko) |
EA (1) | EA016576B1 (ko) |
ES (1) | ES2567130T3 (ko) |
HK (1) | HK1113747A1 (ko) |
HU (1) | HUE027244T2 (ko) |
IL (1) | IL189162A (ko) |
MX (1) | MX2008001673A (ko) |
NZ (1) | NZ566153A (ko) |
PL (1) | PL1930002T3 (ko) |
SI (1) | SI1930002T1 (ko) |
UA (1) | UA90159C2 (ko) |
WO (1) | WO2007014515A1 (ko) |
ZA (1) | ZA200801635B (ko) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102603522B (zh) * | 2011-01-23 | 2015-04-22 | 复旦大学 | 苯酚类衍生物及其在制备抗乙肝病毒药物中的用途 |
KR101401154B1 (ko) * | 2011-02-22 | 2014-05-30 | 경희대학교 산학협력단 | 메틸 갈레이트를 포함하는 조절 t 세포 활성 억제용 약학적 조성물 |
PL404138A1 (pl) * | 2013-05-31 | 2014-12-08 | Warszawski Uniwersytet Medyczny | Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα |
CN103599093B (zh) * | 2013-11-18 | 2016-06-01 | 中国医学科学院生物医学工程研究所 | 一种抗hpv药物制剂及用途 |
CN104784324A (zh) * | 2014-05-15 | 2015-07-22 | 刘善奎 | 治疗***中药栓剂的制法 |
CN108463236A (zh) | 2015-12-18 | 2018-08-28 | 泰伦基国际有限公司 | 一种预防或治疗放射性和化学性损伤的方法 |
TWI623321B (zh) | 2015-12-18 | 2018-05-11 | Talengen Institute Of Life Sciences Co Ltd | Method for preventing and treating cervical erosion |
CN105748506B (zh) * | 2016-03-03 | 2018-08-17 | 青岛海洋生物医药研究院股份有限公司 | 褐藻酸硫酸酯在制备预防和治疗由人***瘤状病毒引起的疾病的药物和保健品中的应用 |
JPWO2019087884A1 (ja) * | 2017-10-31 | 2020-11-19 | 富士フイルム株式会社 | 組成物、抗菌組成物、抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー |
JPWO2019087888A1 (ja) * | 2017-10-31 | 2020-11-12 | 富士フイルム株式会社 | 組成物、抗菌組成物、抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー |
JPWO2019087881A1 (ja) * | 2017-10-31 | 2020-10-22 | 富士フイルム株式会社 | 抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー |
CN111419833B (zh) * | 2020-06-02 | 2023-04-07 | 上海爱启医药技术有限公司 | 没食子酸的药物应用 |
CN114146082A (zh) * | 2020-09-07 | 2022-03-08 | 盈科瑞(横琴)药物研究院有限公司 | 对羟基苯甲酸甲酯及其钠盐抗冠状病毒的用途 |
CN112375803B (zh) * | 2020-11-16 | 2024-05-07 | 石河子大学 | 五倍子中抗炎活性成分没食子酸乙酯的筛选方法及其用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0819380A1 (en) * | 1996-06-07 | 1998-01-21 | Iwao Hishida | Bacteriocidal, antibacterial and bacteriostatic composition |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3929985A (en) * | 1974-01-18 | 1975-12-30 | Richardson Merrell Inc | Anhydrous candicidin foam compositions |
JPS62132824A (ja) * | 1985-12-05 | 1987-06-16 | Eisai Co Ltd | 肝炎への治療剤 |
CN1042298C (zh) * | 1989-07-31 | 1999-03-03 | 安纳利蒂康有限公司 | 含鬼臼毒的乳膏形式的药物组合物的制备方法 |
SE464167B (sv) * | 1989-07-31 | 1991-03-18 | Analytecon Sa | Topisk farmaceutisk beredning av podophyllotoxin |
CN1068782A (zh) * | 1992-01-30 | 1993-02-10 | 展静 | 轮胎气压报警装置 |
NL9500216A (nl) * | 1995-02-06 | 1996-09-02 | Bio Pharma Sciences Bv | Farmaceutische samenstelling voor de behandeling van herpes. |
DE19514694A1 (de) * | 1995-04-13 | 1996-10-17 | Ina Dr Levi | Breitspektrum-Antiinfektivamittel |
JPH0959151A (ja) * | 1995-08-24 | 1997-03-04 | Kao Corp | NF−κB活性化抑制剤 |
CN1068782C (zh) * | 1996-04-18 | 2001-07-25 | 中国医药研究开发中心 | 以栾树提取物为有效组分的抗癌药物及制备方法 |
TW536403B (en) * | 1997-03-24 | 2003-06-11 | Glaxo Group Ltd | An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy |
KR20010013377A (ko) | 1997-06-04 | 2001-02-26 | 데이비드 엠 모이어 | 마일드한 잔류성 항균 조성물 |
KR100765683B1 (ko) * | 2001-05-03 | 2007-10-11 | 파르미게아 에스.피.에이 | 자궁경부 침습질환을 치료하기 위한 수크랄페이트 또는 그의 수크로오스 옥타술레이트 |
-
2005
- 2005-08-02 CN CNB2005100122870A patent/CN100427082C/zh active Active
-
2006
- 2006-07-21 EA EA200800467A patent/EA016576B1/ru unknown
- 2006-07-21 CA CA2617659A patent/CA2617659C/en active Active
- 2006-07-21 AU AU2006275232A patent/AU2006275232B2/en active Active
- 2006-07-21 MX MX2008001673A patent/MX2008001673A/es active IP Right Grant
- 2006-07-21 NZ NZ566153A patent/NZ566153A/en not_active IP Right Cessation
- 2006-07-21 DK DK06761527.8T patent/DK1930002T3/en active
- 2006-07-21 SI SI200632042A patent/SI1930002T1/sl unknown
- 2006-07-21 EP EP06761527.8A patent/EP1930002B1/en active Active
- 2006-07-21 HU HUE06761527A patent/HUE027244T2/en unknown
- 2006-07-21 JP JP2008524341A patent/JP5473328B2/ja active Active
- 2006-07-21 UA UAA200802626A patent/UA90159C2/ru unknown
- 2006-07-21 ES ES06761527.8T patent/ES2567130T3/es active Active
- 2006-07-21 BR BRPI0616536A patent/BRPI0616536B8/pt active IP Right Grant
- 2006-07-21 PL PL06761527T patent/PL1930002T3/pl unknown
- 2006-07-21 WO PCT/CN2006/001792 patent/WO2007014515A1/zh active Application Filing
- 2006-07-21 KR KR1020087005140A patent/KR100922605B1/ko active IP Right Grant
- 2006-07-21 AP AP2008004351A patent/AP2658A/xx active
-
2008
- 2008-01-31 IL IL189162A patent/IL189162A/en active IP Right Grant
- 2008-02-19 ZA ZA200801635A patent/ZA200801635B/xx unknown
- 2008-08-14 HK HK08109037.8A patent/HK1113747A1/zh unknown
-
2016
- 2016-04-05 CY CY20161100272T patent/CY1117480T1/el unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0819380A1 (en) * | 1996-06-07 | 1998-01-21 | Iwao Hishida | Bacteriocidal, antibacterial and bacteriostatic composition |
Non-Patent Citations (1)
Title |
---|
Bioscience Reports Vol.8(1): 95-102 (1998)* |
Also Published As
Publication number | Publication date |
---|---|
ZA200801635B (en) | 2009-06-24 |
AU2006275232A1 (en) | 2007-02-08 |
BRPI0616536A2 (pt) | 2012-12-25 |
EA016576B1 (ru) | 2012-06-29 |
IL189162A (en) | 2014-04-30 |
BRPI0616536B8 (pt) | 2021-05-25 |
KR20080036128A (ko) | 2008-04-24 |
UA90159C2 (ru) | 2010-04-12 |
EP1930002A1 (en) | 2008-06-11 |
PL1930002T3 (pl) | 2016-07-29 |
WO2007014515A1 (fr) | 2007-02-08 |
ES2567130T3 (es) | 2016-04-20 |
JP2009502985A (ja) | 2009-01-29 |
AP2658A (en) | 2013-05-09 |
CA2617659C (en) | 2013-02-26 |
BRPI0616536B1 (pt) | 2020-05-26 |
CN1907276A (zh) | 2007-02-07 |
EP1930002A4 (en) | 2010-04-21 |
HUE027244T2 (en) | 2016-09-28 |
DK1930002T3 (en) | 2016-04-11 |
SI1930002T1 (sl) | 2016-06-30 |
MX2008001673A (es) | 2008-11-06 |
AU2006275232B2 (en) | 2010-12-02 |
CY1117480T1 (el) | 2017-04-26 |
NZ566153A (en) | 2011-07-29 |
CN100427082C (zh) | 2008-10-22 |
CA2617659A1 (en) | 2007-02-08 |
EP1930002B1 (en) | 2016-01-06 |
EA200800467A1 (ru) | 2008-10-30 |
JP5473328B2 (ja) | 2014-04-16 |
HK1113747A1 (zh) | 2008-10-17 |
IL189162A0 (en) | 2008-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100922605B1 (ko) | 바이러스 감염의 예방 및 치료용 약제를 제조하기 위한하이드록시벤조산 에스테르 및 유사체의 용도 | |
US10137140B2 (en) | Therapeutic composition | |
ES2284250T3 (es) | Formulaciones para la prevencion o el tratamiento de enfermedades que afectan a la membrana mucosa o la piel, o para la prevencion del embarazo. | |
CN103920081A (zh) | 一种药物组合物的用途 | |
CN104353058A (zh) | 商陆抗病毒蛋白冻干粉复合剂及其制备方法 | |
WO2007014514A1 (fr) | Utilisation d’acide p-hydroxybenzoïque et d’analogues pour la fabrication d’un médicament pour la prévention et le traitement d’une infection virale d’une muqueuse de peau | |
US8044098B2 (en) | Use of hydroxybenzoic acids and their esters and analogues for preventing or treating virus infection | |
US20180133239A1 (en) | Therapeutic composition | |
CN101342166B (zh) | 羟基苯甲酸酯及其类似物在制备预防和治疗乙型肝炎病毒的药物中的应用 | |
CN105311636B (zh) | 一种抗疱疹病毒软膏剂及其制备方法 | |
CN106177900A (zh) | 一种抗人***瘤病毒的凝胶及其制备方法 | |
JPWO2006011394A1 (ja) | 抗原虫剤 | |
WO2019136196A1 (en) | Therapeutic composition | |
CN104771384A (zh) | 紫草素的医药用途 | |
ES2578902B1 (es) | Uso de análogos del ión pirofosfato para el tratamiento de la infección por VPH | |
WO2019104587A1 (zh) | 一种药物组合物及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120621 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20130927 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20140918 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20150701 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20160720 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20170721 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20181002 Year of fee payment: 10 |